Effect of factor XIII-A Val34Leu polymorphism on myocardial infarction risk: A meta-analysis

Clinical and Applied Thrombosis/Hemostasis

Volumn 20, Issue 8, 2014, Pages 783-792

  Chen, Fei ^a   Qiao, Qi ^a   Xu, Peng ^a   Fan, Bing ^a   Chen, Zaoping ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

factor XIII A; genetics; meta analysis; myocardial infarction

Indexed keywords

BLOOD CLOTTING FACTOR 13A; LEUCINE; VALINE;

ARTICLE; CAUCASIAN; DISEASE PREDISPOSITION; DNA POLYMORPHISM; GROUPS BY AGE; HEART INFARCTION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; RACE DIFFERENCE; RISK ASSESSMENT; SEX DIFFERENCE; SMOKING;

EID: 84921020190     PISSN: 10760296     EISSN: 19382723     Source Type: Journal    
DOI: 10.1177/1076029613504130     Document Type: Article

References (49)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics - 2012 update: a report from the American Heart Association. Circulation. 2012 ; 125 (1). 188-197
2. Kessler T, Erdmann J, Schunkert H. Genetics of coronary artery disease and myocardial infarction-2013. Curr Cardiol Rep. 2013 ; 15 (6). 368
3. Schunkert H, Erdmann J, Samani NJ. Genetics of myocardial infarction: a progress report. Eur Heart J. 2010 ; 31 (8). 918-925
4. Muszbek L, Yee VC, Hevessy Z. Blood coagulation factor xiii: structure and function. Thromb Res. 1999 ; 94 (5). 271-305
5. Nahrendorf M, Aikawa E, Figueiredo JL, et al. Transglutaminase activity in acute infarcts predicts healing outcome and left ventricular remodelling: implications for fxiii therapy and antithrombin use in myocardial infarction. Eur Heart J. 2008 ; 29 (4). 445-454
6. Nahrendorf M, Hu K, Frantz S, et al. Factor xiii deficiency causes cardiac rupture, impairs wound healing, and aggravates cardiac remodeling in mice with myocardial infarction. Circulation. 2006 ; 113 (9). 1196-1202
7. Kohler HP, Stickland MH, Ossei-Gerning N, Carter A, Mikkola H, Grant PJ. Association of a common polymorphism in the factor xiii gene with myocardial infarction. Thromb Haemost. 1998 ; 79 (1). 8-13
8. Wartiovaara U, Perola M, Mikkola H, et al. Association of FXIII VAL34Leu with decreased risk of myocardial infarction in Finnish males. Atherosclerosis. 1999 ; 142 (2). 295-300
9. Canavy I, Henry M, Morange PE, et al. Genetic polymorphisms and coronary artery disease in the south of France. Thromb Haemost. 2000 ; 83 (2). 212-216
10. Corral J, González-Conejero R, Iniesta JA, Rivera J, Martínez C, Vicente V. The FXIII Val34Leu polymorphism in venous and arterial thromboembolism. Haematologica. 2000 ; 85 (3). 293-297
11. Franco RF, Pazin-Filho A, Tavella MH, et al. Factor XIII Val34leu and the risk of myocardial infarction. Haematologica. 2000 ; 85 (1). 67-71
12. Gemmati D, Serino ML, Ongaro A, et al. A common mutation in the gene for coagulation factor XIII-A (val34leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases. Am J Hematol. 2001 ; 67 (3). 183-188
13. Kakko S, Elo T, Tapanainen JM, Huikuri HV, Savolainen MJ. Polymorphisms of genes affecting thrombosis and risk of myocardial infarction. Eur J Clin Invest. 2002 ; 32 (9). 643-648
14. Reiner AP, Frank MB, Schwartz SM, et al. Coagulation factor XIII polymorphisms and the risk of myocardial infarction and ischaemic stroke in young women. Br J Haematol. 2002 ; 116 (2). 376-382
15. No evidence of association between prothrombotic gene polymorphisms and the development of acute myocardial infarction at a young age. Circulation. 2003 ; 107 (8). 1117-1122
16. Butt C, Zheng H, Randell E, Robb D, Parfrey P, Xie YG. Combined carrier status of prothrombin 20210a and factor XIII-A leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction. Blood. 2003 ; 101 (8). 3037-3041
17. Doggen CJ, Reiner AP, Vos HL, Rosendaal FR. Two factor XIII gene polymorphisms associated with a structural and functional defect and the risk of myocardial infarction in men. J Thromb Haemost. 2003 ; 1 (9). 2056-2058
18. Reiner AP, Heckbert SR, Vos HL, et al. Genetic variants of coagulation factor XIII, postmenopausal estrogen therapy, and risk of nonfatal myocardial infarction. Blood. 2003 ; 102 (1). 25-30
19. Feng BL, Xu G, Jin GD, Shi YP, Fu GS, Ma J, Shan j. The relationship between Factor XIII Val34Leu variant and coronary artery disease. Chin J Pathophysiology. 2004 ; 20 (10). 1823-1826
20. Martini CH, Doggen CJ, Cavallini C, Rosendaal FR, Mannucci PM. No effect of polymorphisms in prothrombotic genes on the risk of myocardial infarction in young adults without cardiovascular risk factors. J Thromb Haemost. 2005 ; 3 (1). 177-179
21. Roldán V, González-Conejero R, Marín F, Pineda J, Vicente V, Corral J. Five prothrombotic polymorphisms and the prevalence of premature myocardial infarction. Haematologica. 2005 ; 90 (3). 421-423
22. Tu CQ, Wu JZ, Xie CY, Pan CY, Li JH, Huang MQ, Zhang X, et al. Association between polymorphism of coagulation factor XIII Val34Leu and ischemic arterial thrombotic diseases in han population. Chin J Clin Rehabil. 2005 ; 9 (1). 70-71
23. Hancer VS, Diz-Kucukkaya R, Bilge AK, et al. The association between factor XIII Val34Leu polymorphism and early myocardial infarction. Circ J. 2005 ; 70 (3). 239-242
24. Mannila MN, Eriksson P, Ericsson CG, Hamsten A, Silveira A. Epistatic and pleiotropic effects of polymorphisms in the fibrinogen and coagulation factor xiii genes on plasma fibrinogen concentration, fibrin gel structure and risk of myocardial infarction. Thromb Haemost. 2006 ; 95 (3). 420-427
25. Salazar-Sanchez L, Chaves L, Cartin M, et al. Common polymorphisms and cardiovascular factors in patients with myocardial infarction of costa rica. Rev Biol Trop. 2006 ; 54 (1). 1-11
26. Bereczky Z, Balogh E, Katona E, et al. Modulation of the risk of coronary sclerosis/myocardial infarction by the interaction between factor XIII subunit a Val34Leu polymorphism and fibrinogen concentration in the high risk hungarian population. Thromb Res. 2007 ; 120 (4). 567-573
27. Mannila MN, Eriksson P, Leander K, et al. The association between fibrinogen haplotypes and myocardial infarction in men is partly mediated through pleiotropic effects on the serum il-6 concentration. J Intern Med. 2007 ; 261 (2). 138-147
28. Smith NL, Bis JC, Biagiotti S, et al. Variation in 24 hemostatic genes and associations with non-fatal myocardial infarction and ischemic stroke. J Thromb Haemost. 2008 ; 6 (1). 45-53
29. Rallidis LS, Politou M, Komporozos C, et al. Factor XIII Val34Leu polymorphism and the risk of myocardial infarction under the age of 36 years. Thromb Haemost. 2008 ; 99 (6). 1085-1089
30. Siegerink B, Algra A, Rosendaal FR. Genetic variants of coagulation factor XIII and the risk of myocardial infarction in young women. Br J Haematol. 2009 ; 146 (4). 459-461
31. Guella I, Duga S, Ardissino D, et al. Common variants in the haemostatic gene pathway contribute to risk of early-onset myocardial infarction in the italian population. Thromb Haemost. 2011 ; 106 (4). 655-664
32. Silvain J, Pena A, Vignalou JB, et al. FXIII-A Leu34 genetic variant in premature coronary artery disease: a genotype - phenotype case control study. Thromb Haemost. 2011 ; 106 (3). 511-520
33. Shaffer J, Kammerer C, Dorn J, et al. Polymorphisms in the platelet-specific collagen receptor gp6 are associated with risk of nonfatal myocardial infarction in caucasians. Nutr Metabol Cardiovasc Dis. 2011 ; 21 (8). 546-552
34. Shafey M, Anderson JL, Scarvelis D, et al. Factor XIII Val34Leu variant and the risk of myocardial infarction. A meta-analysis. Thromb Haemost. 2007 ; 97 (8). 635-641
35. Vokó Z, Bereczky Z, Katona É, et al. Factor XIII Val34Leu variant protects against coronary artery disease. A meta-analysis. Thromb Haemost. 2007 ; 97 (3). 458-463
36. Thakkinstian A, McElduff P, D'Este C, Duffy D, Attia J. A method for meta-analysis of molecular association studies. Stat Med. 2005 ; 24 (9). 1291-1306
37. Nie W, Chen J, Xiu Q. Cytotoxic t-lymphocyte associated antigen 4 polymorphisms and asthma risk: a meta-analysis. PLoS One. 2012 ; 7 (7). e42062
38. Nie W, Fang Z, Li B, Xiu QY. Interleukin-10 promoter polymorphisms and asthma risk: a meta-analysis. Cytokine. 2012 ; 60 (3). 849-855
39. Nie W, Liu Y, Bian J, Li B, Xiu Q. Effects of polymorphisms-1112c/t and+ 2044a/g in interleukin-13 gene on asthma risk: a meta-analysis. PLoS One. 2013 ; 8 (2). e56065
40. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997 ; 315 (7190). 629-634
41. Muszbek L. Deficiency causing mutations and common polymorphisms in the factor XIII-A gene. Thromb Haemost. 2000 ; 84 (4). 524-527
42. McCormack LJ, Kain K, Catto AJ, Kohler HP, Stickland MH, Grant PJ. Prevalence of FXIII V34L in populations with different cardiovascular risk. Thromb Haemost. 1998 ; 80 (3). 523-524
43. Attié-Castro FA, Zago MA, Lavinha J, et al. Ethnic heterogeneity of the factor XIII Val34Leu polymorphism. Thromb Haemost. 2000 ; 84 (4). 601-603
44. Ariëns RA, Lai TS, Weisel JW, Greenberg CS, Grant PJ. Role of factor XIII in fibrin clot formation and effects of genetic polymorphisms. Blood. 2002 ; 100 (3). 743-754
45. Ariëns RA, Philippou H, Nagaswami C, Weisel JW, Lane DA, Grant PJ. The factor XIII V34L polymorphism accelerates thrombin activation of factor XIII and affects cross-linked fibrin structure. Blood. 2000 ; 96 (3). 988-995
46. Balogh I, Szôke G, Kárpáti L, et al. Val34Leu polymorphism of plasma factor XIII: biochemistry and epidemiology in familial thrombophilia. Blood. 2000 ; 96 (7). 2479-2486
47. Wartiovaara U, Mikkola H, Szoke G, et al. Effect of Val34Leu polymorphism on the activation of the coagulation factor XIII-A. Thromb Haemost. 2000 ; 84 (4). 595-600
48. Schröder V, Kohler H. Effect of factor XIII Val34Leu on alpha2-antiplasmin incorporation into fibrin. Thromb Haemost. 2000 ; 84 (6). 1128-1130
49. Rubens FD, Perry DW, Hatton MW, Bishop PD, Packham MA, Kinlough-Rathbone RL. Platelet accumulation on fibrin-coated polyethylene: role of platelet activation and factor XIII. Thromb Haemost. 1995 ; 73 (5). 850-856